PMGC Holdings Inc. (ELAB) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 5, 2026, PMGC Holdings Inc. (ELAB) trades at a price-to-earnings ratio of -0.0x, with a stock price of $1.05 and trailing twelve-month earnings per share of $-12.60.
Compared to the Healthcare sector median P/E of 23.2x, ELAB trades at a 100% discount to its sector peers. The sector includes 226 companies with P/E ratios ranging from 0.0x to 194.6x.
Relative to the broader market, ELAB trades at a notable discount to the S&P 500 median P/E of 26.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ELAB DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
See ELAB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ELAB Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ELAB vs LLY
See how ELAB stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is ELAB stock overvalued or undervalued?
ELAB current P/E: -0.0x. 5-year average P/E: N/A. Percentile: N/A.
How does ELAB's valuation compare to peers?
PMGC Holdings Inc. P/E of -0.0x compares to sector median of 23.2x. Sector comparison provides relative valuation context.
What is ELAB's PEG ratio?
ELAB PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.